Mathilde Lafon
Bordeaux, 33076, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Estimating Metastatic Disease Heterogeneity Using Radiomics-based Lesion Clustering and Heterogeneity Index - Application in Lung Adenocarcinoma Patients and Correlations With Patient Outcomes.
Journal: Journal of imaging informatics in medicine
Published: March 31, 2026
Dual inhibition of BET and EP300 has antitumor activity in undifferentiated pleomorphic sarcomas and synergizes with ferroptosis induction.
Journal: Translational oncology
Published: August 06, 2024
Single- and multi-site radiomics may improve overall survival prediction for patients with metastatic lung adenocarcinoma.
Journal: Diagnostic and interventional imaging
Published: June 09, 2024
Metastatic Lung Adenocarcinomas: Development and Evaluation of Radiomic-Based Methods to Measure Baseline Intra-Patient Inter-Tumor Lesion Heterogeneity.
Journal: Journal of imaging informatics in medicine
Published: February 16, 2024
Ranking the most influential predictors of CT-based radiomics feature values in metastatic lung adenocarcinoma.
Journal: European journal of radiology
Published: January 10, 2022
Atezolizumab for the treatment of renal cell carcinoma.
Journal: Expert opinion on biological therapy
Published: April 05, 2020
Sarcoidosis-like reaction in metastatic triple negative breast cancer treated by anti-PD-L1.
Journal: The breast journal
Published: March 22, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026